Chia Tai Enterprises International Limited (HKG:3839)

Hong Kong · Delayed Price · Currency is HKD

9.50

+0.10 (1.06%)

Jul 10, 2026, 4:08 PM HKT

83.75% (1Y)

Market Cap	2.41B +394.8%
Revenue (ttm)	3.68B +12.4%
Net Income	235.26M +67.9%
EPS	0.93
Shares Out	253.33M
PE Ratio	10.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,500
Open	9.64
Previous Close	9.40
Day's Range	9.28 - 9.65
52-Week Range	4.73 - 10.15
Beta	3.99
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About HKG:3839

Chia Tai Enterprises International Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments: Biotech Business and Investment Business. The Biochemical segment is engaged in the manufacture and/or sale of animal health products and chlortetracycline, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance efficiency under the Shihao and Citifac brand names. The I... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1987

Employees 900

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 3839

Full Company Profile

Financial Performance

In 2025, HKG:3839's revenue was $535.91 million, an increase of 74.14% compared to the previous year's $307.75 million. Earnings were $32.06 million, an increase of 187.03%.

Financial numbers in USD Financial Statements